• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Urinary Microvesicle-Bound Uromodulin: A Potential Molecular Biomarker in Diabetic Kidney Disease.尿微泡结合的尿调节蛋白:糖尿病肾病的一种潜在分子生物标志物。
J Diabetes Res. 2017;2017:3918681. doi: 10.1155/2017/3918681. Epub 2017 Jan 15.
2
Dipeptidyl peptidase-IV is a potential molecular biomarker in diabetic kidney disease.二肽基肽酶-4 是糖尿病肾病的潜在分子生物标志物。
Diab Vasc Dis Res. 2012 Oct;9(4):301-8. doi: 10.1177/1479164111434318. Epub 2012 Mar 2.
3
Uromodulin mRNA from Urinary Extracellular Vesicles Correlate to Kidney Function Decline in Type 2 Diabetes Mellitus.尿细胞外囊泡中的尿调蛋白 mRNA 与 2 型糖尿病患者的肾功能下降相关。
Am J Nephrol. 2018;47(5):283-291. doi: 10.1159/000489129. Epub 2018 May 18.
4
Urinary glycated uromodulin in diabetic kidney disease.糖尿病肾病患者尿液糖化尿调蛋白。
Clin Sci (Lond). 2017 Jul 5;131(15):1815-1829. doi: 10.1042/CS20160978. Print 2017 Aug 1.
5
The changes of serum sKlotho and NGAL levels and their correlation in type 2 diabetes mellitus patients with different stages of urinary albumin.2型糖尿病不同尿白蛋白阶段患者血清sKlotho和NGAL水平变化及其相关性
Diabetes Res Clin Pract. 2014 Nov;106(2):343-50. doi: 10.1016/j.diabres.2014.08.026. Epub 2014 Sep 16.
6
Identification of urinary soluble E-cadherin as a novel biomarker for diabetic nephropathy.鉴定尿可溶性E-钙黏蛋白作为糖尿病肾病的一种新型生物标志物。
Diabetes Metab Res Rev. 2009 Mar;25(3):232-41. doi: 10.1002/dmrr.940.
7
Performance of urinary neutrophil gelatinase-associated lipocalin, clusterin, and cystatin C in predicting diabetic kidney disease and diabetic microalbuminuria: a consecutive cohort study.尿中性粒细胞明胶酶相关脂质运载蛋白、簇集蛋白和胱抑素C在预测糖尿病肾病和糖尿病微量白蛋白尿中的表现:一项连续队列研究。
BMC Nephrol. 2017 Jul 12;18(1):233. doi: 10.1186/s12882-017-0620-8.
8
Urinary heme oxygenase-1 as a potential biomarker for early diabetic nephropathy.尿血红素加氧酶-1作为早期糖尿病肾病的潜在生物标志物。
Nephrology (Carlton). 2017 Jan;22(1):58-64. doi: 10.1111/nep.12719.
9
Markers of Glomerular and Tubular Damage in the Early Stage of Kidney Disease in Type 2 Diabetic Patients.2 型糖尿病患者肾脏疾病早期肾小球和肾小管损伤的标志物。
Mediators Inflamm. 2018 Aug 9;2018:7659243. doi: 10.1155/2018/7659243. eCollection 2018.
10
Adipokine zinc-alpha-2-glycoprotein as a novel urinary biomarker presents earlier than microalbuminuria in diabetic nephropathy.脂肪因子锌-α-2-糖蛋白作为一种新型尿液生物标志物,在糖尿病肾病中比微量白蛋白尿出现得更早。
J Int Med Res. 2016 Apr;44(2):278-86. doi: 10.1177/0300060515601699. Epub 2016 Feb 8.

引用本文的文献

1
Role of exosomes in pathogenesis, diagnosis, and treatment of diabetic nephropathy.外泌体在糖尿病肾病发病机制、诊断及治疗中的作用
BMC Nephrol. 2025 May 8;26(1):230. doi: 10.1186/s12882-025-04120-4.
2
The role of exosomes in the pathogenesis and management of diabetic kidney disease: a systematic review and meta-analysis.外泌体在糖尿病肾病发病机制及治疗中的作用:一项系统综述和荟萃分析
Front Endocrinol (Lausanne). 2024 Dec 3;15:1398382. doi: 10.3389/fendo.2024.1398382. eCollection 2024.
3
Exosomal UMOD gene expression and urinary uromodulin level as early noninvasive diagnostic biomarkers for diabetic nephropathy in type 2 diabetic patients.外泌体UMOD基因表达和尿调节素水平作为2型糖尿病患者糖尿病肾病的早期非侵入性诊断生物标志物。
Diabetol Int. 2024 Feb 12;15(3):389-399. doi: 10.1007/s13340-023-00686-2. eCollection 2024 Jul.
4
Unveiling the Hidden Power of Uromodulin: A Promising Potential Biomarker for Kidney Diseases.揭示尿调节蛋白的隐藏力量:一种有前景的肾脏疾病潜在生物标志物。
Diagnostics (Basel). 2023 Sep 28;13(19):3077. doi: 10.3390/diagnostics13193077.
5
The Promise of Systems Biology for Diabetic Kidney Disease.系统生物学在糖尿病肾病中的应用前景。
Adv Chronic Kidney Dis. 2018 Mar;25(2):202-213. doi: 10.1053/j.ackd.2017.10.012.

本文引用的文献

1
Kidney tissue proteomics reveals regucalcin downregulation in response to diabetic nephropathy with reflection in urinary exosomes.肾脏组织蛋白质组学揭示了糖尿病肾病中规钙素的下调,并在尿外泌体中得到反映。
Transl Res. 2015 Nov;166(5):474-484.e4. doi: 10.1016/j.trsl.2015.05.007. Epub 2015 May 23.
2
Use and isolation of urinary exosomes as biomarkers for diabetic nephropathy.尿外泌体作为糖尿病肾病生物标志物的应用与分离
Front Endocrinol (Lausanne). 2014 Sep 26;5:149. doi: 10.3389/fendo.2014.00149. eCollection 2014.
3
Diabetic kidney disease: from epidemiology to clinical perspectives.糖尿病肾病:从流行病学到临床视角。
Diabetes Metab J. 2014 Aug;38(4):252-60. doi: 10.4093/dmj.2014.38.4.252.
4
Microvesicles and diabetic complications--novel mediators, potential biomarkers and therapeutic targets.微泡与糖尿病并发症——新型介质、潜在生物标志物及治疗靶点
Acta Pharmacol Sin. 2014 Apr;35(4):433-43. doi: 10.1038/aps.2013.188. Epub 2014 Mar 10.
5
Urinary exosomal Wilms' tumor-1 as a potential biomarker for podocyte injury.尿外泌体 Wilms' 肿瘤-1 作为足细胞损伤的潜在生物标志物。
Am J Physiol Renal Physiol. 2013 Aug 15;305(4):F553-9. doi: 10.1152/ajprenal.00056.2013. Epub 2013 Jun 12.
6
Changes in the expression of bone morphogenetic protein 7 and tamm- horsfall protein in the early stages of diabetic nephropathy.糖尿病肾病早期骨形态发生蛋白7和Tamm-Horsfall蛋白表达的变化
Nephrourol Mon. 2012 Spring;4(2):466-9. doi: 10.5812/numonthly.2124. Epub 2012 Mar 1.
7
Wilm's tumor-1 protein levels in urinary exosomes from diabetic patients with or without proteinuria.尿外泌体中 Wilm's 肿瘤-1 蛋白水平在有或无蛋白尿的糖尿病患者中的变化。
PLoS One. 2013;8(3):e60177. doi: 10.1371/journal.pone.0060177. Epub 2013 Mar 27.
8
Urine haptoglobin levels predict early renal functional decline in patients with type 2 diabetes.尿结合珠蛋白水平可预测 2 型糖尿病患者的早期肾功能下降。
Kidney Int. 2013 Jun;83(6):1136-43. doi: 10.1038/ki.2013.57. Epub 2013 Mar 27.
9
Urinary exosomes and diabetic nephropathy: a proteomic approach.尿液外泌体与糖尿病肾病:一种蛋白质组学方法
Mol Biosyst. 2013 Jun;9(6):1139-46. doi: 10.1039/c2mb25396h.
10
Epidemiology of diabetic kidney disease.糖尿病肾病的流行病学。
Med Clin North Am. 2013 Jan;97(1):1-18. doi: 10.1016/j.mcna.2012.10.001.

尿微泡结合的尿调节蛋白:糖尿病肾病的一种潜在分子生物标志物。

Urinary Microvesicle-Bound Uromodulin: A Potential Molecular Biomarker in Diabetic Kidney Disease.

作者信息

Lou Neng-Jun, Ni Yi-Hong, Jia Hong-Ying, Deng Jing-Ti, Jiang Lu, Zheng Feng-Jie, Sun Ai-Li

机构信息

The Second Hospital of Shandong University, 247 Beiyuan Street, Ji'nan, Shandong 250033, China.

Department of Biochemistry, School of Medicine of Shandong University, Shandong, China.

出版信息

J Diabetes Res. 2017;2017:3918681. doi: 10.1155/2017/3918681. Epub 2017 Jan 15.

DOI:10.1155/2017/3918681
PMID:28182086
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5274657/
Abstract

This study was designed to investigate the changes of urinary microvesicle-bound uromodulin and total urinary uromodulin levels in human urine and the correlations with the severity of diabetic kidney disease (DKD). 31 healthy subjects without diabetes and 100 patients with type 2 diabetes mellitus (T2DM) were included in this study. The patients with T2DM were divided into three groups based on the urinary albumin/creatinine ratio (UACR): normoalbuminuria group (DM, = 46); microalbuminuria group (DN1, = 32); and macroalbuminuria group (DN2, = 22). We use a specific monoclonal antibody AD-1 to capture the urinary microvesicles. Urinary microvesicle-bound uromodulin and total urinary uromodulin levels were determined by enzyme-linked immunosorbent assay (ELISA). Our results showed that the levels of urinary microvesicle-bound uromodulin in DN1 and DN2 groups were significantly higher than those in control group and DM group ( < 0.01). Multiple stepwise linear regression analysis showed that UACR was independent determinant for urinary microvesicle-bound uromodulin ( < 0.05) but not for total urinary uromodulin. These findings suggest that the levels of urinary microvesicle-bound uromodulin are associated with the severity of DKD. The uromodulin in urinary microvesicles may be a specific marker of DKD and potentially may be used to predict the onset and/or monitor the progression of DKD.

摘要

本研究旨在探讨人尿中尿微泡结合型尿调节蛋白和总尿调节蛋白水平的变化及其与糖尿病肾病(DKD)严重程度的相关性。本研究纳入了31名无糖尿病的健康受试者和100名2型糖尿病(T2DM)患者。T2DM患者根据尿白蛋白/肌酐比值(UACR)分为三组:正常白蛋白尿组(DM,n = 46);微量白蛋白尿组(DN1,n = 32);和大量白蛋白尿组(DN2,n = 22)。我们使用特异性单克隆抗体AD-1捕获尿微泡。通过酶联免疫吸附测定(ELISA)测定尿微泡结合型尿调节蛋白和总尿调节蛋白水平。我们的结果显示,DN1组和DN2组的尿微泡结合型尿调节蛋白水平显著高于对照组和DM组(P < 0.01)。多元逐步线性回归分析显示,UACR是尿微泡结合型尿调节蛋白的独立决定因素(P < 0.05),但不是总尿调节蛋白的独立决定因素。这些发现表明,尿微泡结合型尿调节蛋白水平与DKD的严重程度相关。尿微泡中的尿调节蛋白可能是DKD的特异性标志物, potentially may be used to predict the onset and/or monitor the progression of DKD.(原文此处表述有误,正确表述可能是“and potentially may be used to predict the onset and/or monitor the progression of DKD.”,翻译为“并且有可能用于预测DKD的发病和/或监测其进展”) 可能可用于预测DKD 的发病和/或监测其进展。